Researchers collaborate on substance to repel blood clots and bacteria

December 5, 2014 by Luke Ng & Sydney Goodfellow, University of Toronto
Glass slides dipped in blood to demonstrate the effectiveness of the nonstick material Credit: Wyss Institute for Biologically Inspired Engineering, Harvard University

Engineering a surface that is so slippery even geckos can't stick to it may sound like a fun science fair project.

But new surface-coating technology developed by materials science and engineering professor Ben Hatton, together with colleagues at Harvard University's Wyss Institute, does just that – and its slick properties have the potential to save lives.

Published recently in Nature Biotechnology, Hatton's innovative design prevents from clotting on medical devices such as catheters, dialysis equipment and heart-lung machines, which is a common problem and can be dangerous.

Blood clotting is an important process in your body, where platelets and proteins in the blood aggregate to seal a wound. However, blood also clots on foreign objects in the body, like catheter tubing, and this clotting can cause blockage of flow or flowing elsewhere in the body.

To counteract these negative effects, doctors and nurses often give patients blood thinners, but these medications can be difficult for those who are elderly, sick or severely wounded.

The problem is so significant it is sparking a number of innovative remedies – including award-winning work by Professor Paul Santerre on a method of infusing anti-clotting macromolecules into during the manufacturing process.

The new coating developed by Professor Hatton and his colleagues matches perfluorcarbons – a liquid that is chemically similar to Teflon – to a uniquely-engineered surface. The result is an ultra-low-adhesion, slippery material that repels blood, stopping the clotting process before it starts.

"Making an inert surface for blood contact is really a huge benefit for a wide range of medical procedures – we really just want blood to ignore that surface and not clot," said Professor Hatton in a recent CBC Radio Quirks & Quarks interview. (Listen here)

To demonstrate this, the research team tested the coating on over 20 different medical surfaces and with in vivo tests. The results were promising: much less blood clot formation for the eight-hour duration of the experiments, without the use of .

In addition to blood, Hatton's technology has also shown to have profound antimicrobial applications – if liquids can't stick to it, it turns out bacteria have a hard time as well.

"Most antimicrobial materials function by releasing a chemical that kills bacteria on contact," said Hatton, explaining that some bacteria become resistant to these products.

"Our approach is different in that the surface of the material is just too slippery for bacteria to adhere to, so no chemical release may be needed."

Aside from blood and bacteria, the Harvard research team also brought a gecko into the lab to test the coating's slippery potential. The gecko – a creature whose footpads are known for their ability to scale smooth walls and stick to almost any material – was also unable to get a grip, sliding off when tilted.

"I think this is going to make everybody's life a whole lot easier in the medical community and for patients as well," said Professor Hatton. "Everyone but geckos, that is."

Explore further: Some painkillers tied to bleeding risk in those with abnormal heartbeat

More information: "A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling." Nature Biotechnology 32, 1134–1140 (2014) DOI: 10.1038/nbt.3020

Related Stories

Some painkillers tied to bleeding risk in those with abnormal heartbeat

November 18, 2014
(HealthDay)—People with the abnormal heartbeat known as atrial fibrillation who take common painkillers might significantly increase their risk for bleeding and blood clots, according to a new study.

A tick's spit leads to an entire lesson in blood clotting

July 1, 2013
There really is such a thing as tick spit – that is, the saliva of a tick. And there's something about it that might help fight heart disease and stroke.

Platelets modulate clotting behavior by 'feeling' their surroundings

September 22, 2014
Platelets, the tiny cell fragments whose job it is to stop bleeding, are very simple. They don't have a cell nucleus. But they can "feel" the physical environment around them, researchers at Emory and Georgia Tech have discovered.

Laser-controlled molecular switch turns blood clotting on, off on command

July 24, 2013
Researchers have designed tiny, light-controlled gold particles that can release DNA controls to switch blood clotting off and on. The results are reported July 24 in the open access journal PLoS ONE by Kimberly Hamad-Schifferli ...

Recommended for you

Team develops new way to grow blood vessels

August 17, 2018
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed ...

New imaging technique can spot tuberculosis infection in an hour

August 16, 2018
Guided by glowing bacteria, researchers have devised an imaging technique that can diagnose live tuberculosis in an hour and help monitor the efficacy of treatments. That's particularly critical because many TB strains have ...

Obesity, infertility and oxidative stress in mouse egg cells

August 16, 2018
Excessive body fat is associated with negative effects on female fertility and pregnancy. In mice, maternal obesity impairs proper development of egg precursor cells called oocytes. In a recent paper published in Molecular ...

Research shows it's possible to reverse damage caused by aging cells

August 15, 2018
What's the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.

This matrix delivers healing stem cells to injured elderly muscles

August 15, 2018
A car accident leaves an aging patient with severe muscle injuries that won't heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method ...

Male tobacco smokers have brain-wide reduction of CB1 receptors

August 15, 2018
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.